# Comparison of whole-body muscle imaging findings between GNE myopathy and other young adult-onset hereditary myopathies

**Authors:** Pattira Boonsri, Suppakorn Yamutai, Pramot Tanutit, Jirakit Sattayapornpipat, Chariyawan Charalsawadi, Prut Koonalintip, Pornchai Sathirapanya, Suwanna Setthawatcharawanich, Rattana Leelawattana, Pat Korathanakhun, Mainak Bardhan, Mainak Bardhan, Vinay Kumar, Vinay Kumar

PMC · DOI: 10.1371/journal.pone.0341031 · PLOS One · 2026-01-23

## TL;DR

This study uses whole-body MRI to compare muscle changes in GNE myopathy with other hereditary muscle diseases, identifying unique patterns that help distinguish GNE myopathy.

## Contribution

The study introduces whole-body MRI as a tool to differentiate GNE myopathy from other young adult-onset hereditary myopathies using specific muscle patterns.

## Key findings

- GNE myopathy shows a classic quadriceps sparing pattern with prominent fatty tissue replacement in specific muscles.
- Latissimus dorsi in GNE myopathy patients had significantly less fatty tissue replacement compared to other hereditary myopathies.
- Subtle active inflammation was observed in GNE myopathy, alongside periscapular weakness.

## Abstract

Previous muscle imaging studies of GNE myopathy are limited to the lower extremities. This study aimed to use whole-body MRI to differentiate between GNE myopathy and other young adult-onset hereditary myopathies.

This retrospective cohort study recruited patients with GNE myopathy or young adult-onset hereditary with limb girdle weakness pattern followed up in a single-center neuromuscular clinical registry between 2019 and 2023. Fatty tissue replacement was evaluated using a 5-point scale using T1-weighted images (T1WI) and proton-density fat fractions (PDFF) from mDIXON Quant images. Inflammation was evaluated using short tau inversion recovery imaging. The distribution and severity of muscle involvement in GNE myopathy were visualized using heat maps, and the parameters were tested for significance.

Of 103 patients, five with GNE myopathy and 10 with young adult-onset hereditary myopathy were recruited. Prominent fatty tissue replacement was seen in specific muscles with subtle active inflammation in GNE myopathy. The comparison of fatty tissue replacement between GNE and other young adult-onset hereditary myopathies exhibited the classic quadriceps sparing pattern in GNE myopathy group. Beyond these findings, latissimus dorsi showed the significantly lower fatty tissue replacement in the GNE group (median [IQR] of T1WI grade 1 [0, 1] vs. 3 [1, 3.4], p = 0.04) and mean (± S.D.) of PDFF in mDIXON Quant (19.0 ± 9.7 vs. 42.6 ± 22.7, p = 0.04).

The latissimus dorsi sparing out of proportion to periscapular weakness would be a novel differentiative feature of GNE myopathy.

## Linked entities

- **Diseases:** GNE myopathy (MONDO:0011603)

## Full-text entities

- **Genes:** GNE (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) [NCBI Gene 10020] {aka DMRV, GLCNE, IBM2, NM, THC12, Uae1}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, FAS (Fas cell surface death receptor) [NCBI Gene 355] {aka ALPS1A, APO-1, APT1, CD95, FAS1, FASTM}, MYH7 (myosin heavy chain 7) [NCBI Gene 4625] {aka CMD1S, CMH1, CMYO7A, CMYO7B, CMYP7A, CMYP7B}, ANO5 (anoctamin 5) [NCBI Gene 203859] {aka GDD1, LGMD2L, LGMDR12, TMEM16E}
- **Diseases:** distal myopathy (MESH:D049310), Calpainopathy (MESH:C535895), GNE (MESH:C536816), LGMDR2 (MESH:C535899), STIR (MESH:D007446), muscle damage (MESH:D009133), myopathies (MESH:D009135), biceps femoris short head muscle edema (MESH:D006258), Fatty tissue replacement (MESH:D008067), muscle weakness (MESH:D018908), LGMDR12 (MESH:C566968), Latissimus dorsi muscle sparing (MESH:D019042), dysferlinopathy (MESH:C537995), LGMDR3-6 (MESH:D058088), edema (MESH:D004487), LGMD (MESH:D049288), autosomal recessive hereditary myopathy (MESH:D009386), foot drop (MESH:D020427), end-stage muscle disease (MESH:D007676), Inflammation (MESH:D007249), desminopathy (MESH:C580316), muscle involvement (MESH:C566343), FSHD (MESH:C536391), becker muscular dystrophy (MESH:D020388)
- **Chemicals:** DIXON (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** c.1664C > T, c.608G > A, c.2179G > A, c.1000G > A
- **Cell lines:** NM — Bos taurus (Bovine), Finite cell line (CVCL_3074)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829776/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829776/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12829776/full.md

---
Source: https://tomesphere.com/paper/PMC12829776